Breaking News Instant updates and real-time market news.

2022-05-23 07:29:12 IMCR Immunocore $30.25 / +1.13 (+3.88%) 07:29 05/23/22 05/23 07:29 05/23/22 07:29	Immunocore and Medison Pharma extend multi-territorial agreement for Kimmtrak Immunocore announced the addition of new markets to its multi-territorial agreement with Medison Pharma, a global pharma company. The multi-territorial agreement to help seek regulatory authorization and commercialize Immunocore's Kimmtrak for the treatment of unresectable or metastatic uveal melanoma, a rare and aggressive form of melanoma that affects the eye, which covers Canada, twenty markets across Central Eastern Europe and Israel, will now extend to Australia and New Zealand. Kimmtrak has been approved by both by the FDA and the EMA, where it is the first and only treatment approved in the E.U. to treat patients with unresectable or metastatic uveal melanoma. Kimmtrak has been granted Breakthrough Therapy Designation, Fast Track designation and orphan drug designation by the FDA in the United States, Accelerated Assessment by the EMA, and Promising Innovative Medicine designation under the UK Early Access to Medicines Scheme for metastatic uveal melanoma.

2022-05-23 07:29:12

IMCR

Immunocore

$30.25 / +1.13 (+3.88%)

07:29

05/23/22

05/23

07:29

05/23/22

07:29

Immunocore and Medison Pharma extend multi-territorial agreement for Kimmtrak

Immunocore announced the addition of new markets to its multi-territorial agreement with Medison Pharma, a global pharma company. The multi-territorial agreement to help seek regulatory authorization and commercialize Immunocore's Kimmtrak for the treatment of unresectable or metastatic uveal melanoma, a rare and aggressive form of melanoma that affects the eye, which covers Canada, twenty markets across Central Eastern Europe and Israel, will now extend to Australia and New Zealand. Kimmtrak has been approved by both by the FDA and the EMA, where it is the first and only treatment approved in the E.U. to treat patients with unresectable or metastatic uveal melanoma. Kimmtrak has been granted Breakthrough Therapy Designation, Fast Track designation and orphan drug designation by the FDA in the United States, Accelerated Assessment by the EMA, and Promising Innovative Medicine designation under the UK Early Access to Medicines Scheme for metastatic uveal melanoma.

OTHER BREAKING NEWS FROM THE FLY

Options	Groupon call volume above normal and directionally bullish » 14:45 08/16/22 08/16 14:45 08/16/22 14:45 GRPN Groupon $14.01 / +1.15 (+8.94%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options GRPN Groupon $14.01 / +1.15 (+8.94%) 08/09/22 Groupon: Layoffs include payroll and nonpayroll reductions 08/09/22 Groupon sees Q3 adjusted EBITDA lower than Q2 08/09/22 Groupon sees 15%-20% sustainable annual adjusted EBITDA margins in 2023 08/08/22 Groupon falls 6.9% to $12.92 after Q2 results and withdrawal of FY22 guidance GRPN Groupon $14.01 / +1.15 (+8.94%) 08/10/22 Barclays Groupon price target lowered to $10 from $12 at Barclays 05/10/22 Wedbush Groupon price target lowered to $15 from $22 at Wedbush 05/10/22 Barclays Groupon price target lowered to $12 from $20 at Barclays 05/10/22 Credit Suisse Groupon price target lowered to $23 from $29 at Credit Suisse GRPN Groupon $14.01 / +1.15 (+8.94%) 08/08/22 Groupon withdraws FY22 guidance, affirms FY23 targets. 08/08/22 Groupon reports Q2 EPS (34c), consensus (44c) 05/09/22 Groupon sees FY22 revenue $670M-$700M, consensus $837.08M 05/09/22 Groupon reports Q1 EPS (80c), consensus (52c) GRPN Groupon $14.01 / +1.15 (+8.94%) 08/08/22 Groupon lays off over 500 employees, TechCrunch reports GRPN Groupon $14.01 / +1.15 (+8.94%) 05/09/22 Fly Intel: After-Hours Movers 04/11/22 Fly Insider: Icosavax, Analog Devices among week's notable insider trades 02/28/22 Fly Intel: After-Hours Movers GRPN Groupon $14.01 / +1.15 (+8.94%) 08/08/22 Groupon options imply 14.1% move in share price post-earnings 08/08/22 Unusually active option classes on open August 8th 05/09/22 Groupon options imply 15.1% move in share price post-earnings 02/28/22 Groupon options imply 12.0% move in share price post-earnings
Recommendations	On Holding price target raised to $31 from $28 at Stifel » 14:36 08/16/22 08/16 14:36 08/16/22 14:36 ONON On Holding $24.05 / -0.415 (-1.70%) Stifel analyst Jim Duffy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events Options ONON On Holding $24.05 / -0.415 (-1.70%) 05/17/22 On Holding rises 15.0% 03/18/22 On Holding rises 9.4% 03/18/22 On Holding rises 7.2% ONON On Holding $24.05 / -0.415 (-1.70%) 07/26/22 OTR Global On Holding initiated with a Positive view at OTR Global 07/25/22 Piper Sandler On Holding initiated with an Overweight at Piper Sandler 07/20/22 Stifel On Holding price target lowered to $28 from $31 at Stifel 07/15/22 UBS On Holding price target lowered to $25 from $39 at UBS ONON On Holding $24.05 / -0.415 (-1.70%) 10:03 Today On Holding raises FY22 net sales view to CHF 1.1B 10:01 Today On Holding reports Q2 adjusted EPS CHF 0.14 vs. CHF 0.05 last year 05/17/22 On Holding expects FY22 net sales to exceed CHF 1.04B 05/17/22 On Holding reports Q1 net income CHF 14.3M vs CHF (10.5M) last year 15 Sep ONON On Holding $24.05 / -0.415 (-1.70%) 08/12/22 Sell these stocks now, proven algorithm says 06/12/22 Sell these stocks now, proven algorithm says 05/27/22 Sell these stocks now, proven algorithm says 05/09/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08:00 Today On Holding - ONON ONON On Holding $24.05 / -0.415 (-1.70%) 03/18/22 Unusually active option classes on open March 18th
Recommendations	Toronto-Dominion price target lowered to C$97 from C$100 at CIBC » 14:34 08/16/22 08/16 14:34 08/16/22 14:34 TD Toronto-Dominion $69.01 / +1.52 (+2.25%) CIBC analyst Paul Holden… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events TD Toronto-Dominion $69.01 / +1.52 (+2.25%) 08/02/22 TD Bank to acquire Cowen in cash transaction valued at $1.3B or $39 per share 08/02/22 Charles Schwab repurchases $1B of shares from Toronto-Dominion 08/01/22 TD Bank Group sells 28.4M shares of Schwab common stock 07/19/22 TD Bank Group comments on expected impact of Charles Schwab's Q2 earnings TD Toronto-Dominion $69.01 / +1.52 (+2.25%) 07/13/22 Stifel Toronto-Dominion price target lowered to C$93 from C$97 at Stifel 07/05/22 Piper Sandler Cowen acquisition could be accretive to TD, says Piper Sandler 05/27/22 Stifel Toronto-Dominion price target raised to C$97 from C$95 at Stifel 05/27/22 National Bank Toronto-Dominion price target raised to C$102 from C$100 at National Bank TD Toronto-Dominion $69.01 / +1.52 (+2.25%) 05/26/22 Toronto-Dominion reports Q2 adjusted EPS C$2.02 vs. C$2.04 last year 03/03/22 Toronto-Dominion reports Q1 adjusted EPS C$2.08 vs. C$1.83 last year TD Toronto-Dominion $69.01 / +1.52 (+2.25%) 08/01/22 TD Bank approaches deal to acquire Cowen, WSJ reports 07/07/22 Toronto-Dominion mentioned cautiously by Bear Cave's Dorsey 07/01/22 Toronto-Dominion looking into takeover of Cowen, Bloomberg reports 04/07/22 Trudeau windfall tax to hit Canadian banks and insurers, Bloomberg reports TD Toronto-Dominion $69.01 / +1.52 (+2.25%) 08/02/22 What You Missed On Wall Street On Tuesday 08/02/22 What You Missed On Wall Street This Morning 08/02/22 Fly Intel: Pre-market Movers 07/07/22 What You Missed On Wall Street On Thursday 08/25/22 Toronto-Dominion - TD
Recommendations	National Bank of Canada price target raised to C$104 from C$102 at CIBC » 14:33 08/16/22 08/16 14:33 08/16/22 14:33 NTIOF National Bank of Canada $72.32 / -0.7887 (-1.08%) CIBC analyst Paul Holden… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research NTIOF National Bank of Canada $72.32 / -0.7887 (-1.08%) 07/13/22 National Bank of Canada raises Canadian prime rate to 4.7% from 3.7% NTIOF National Bank of Canada $72.32 / -0.7887 (-1.08%) 05/31/22 CIBC National Bank of Canada price target raised to C$102 from C$100 at CIBC 05/31/22 Credit Suisse National Bank of Canada price target raised to C$111 from C$106 at Credit Suisse 05/31/22 Desjardins National Bank of Canada price target lowered to C$103 from C$104 at Desjardins 05/20/22 Scotiabank National Bank of Canada price target lowered to C$106 from C$108 at Scotiabank
Recommendations	Laurentian Bank price target raised to C$46 from C$43 at CIBC » 14:33 08/16/22 08/16 14:33 08/16/22 14:33 LRCDF Laurentian Bank $33.06 / + (+0.00%) CIBC analyst Paul Holden… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings LRCDF Laurentian Bank $33.06 / + (+0.00%) 07/28/22 Laurentian Bank increases USD base rate in Canada 06/16/22 Laurentian Bank increases USD base rate in Canada 06/01/22 Laurentian Bank increases dividend to 45c per share 04/13/22 Laurentian Bank of Canada raises prime lending rate to 3.2% from 2.7% LRCDF Laurentian Bank $33.06 / + (+0.00%) 06/02/22 Credit Suisse Laurentian Bank price target raised to C$43 from C$39 at Credit Suisse 06/02/22 RBC Capital Laurentian Bank price target raised to C$53 from C$52 at RBC Capital 06/02/22 National Bank Laurentian Bank price target raised to C$53 from C$49 at National Bank 06/02/22 Stifel Laurentian Bank price target raised to C$44 from C$40 at Stifel LRCDF Laurentian Bank $33.06 / + (+0.00%) 03/02/22 Laurentian Bank reports Q1 adjusted EPS C$1.26 vs. C$1.03 last year
Recommendations	Hardwoods Distribution price target raised to C$46 from C$41 at CIBC » 14:33 08/16/22 08/16 14:33 08/16/22 14:33 HDIUF Hardwoods Distribution $26.50 / + (+0.00%) CIBC analyst Hamir Patel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research HDIUF Hardwoods Distribution $26.50 / + (+0.00%) 08/04/22 TD Securities Hardwoods Distribution price target lowered to C$64 from C$73 at TD Securities 05/16/22 Canaccord Hardwoods Distribution price target raised to C$63 from C$60 at Canaccord 05/16/22 TD Securities Hardwoods Distribution price target raised to C$73 from C$64 at TD Securities 04/11/22 Canaccord Hardwoods Distribution price target lowered to C$60 from C$73 at Canaccord
Downgrade	Odeon Capital downgrades Bed Bath & Beyond to Sell with $7.50 price target » 14:32 08/16/22 08/16 14:32 08/16/22 14:32 BBBY Bed Bath & Beyond $26.77 / +10.775 (+67.36%) As previously reported,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options BBBY Bed Bath & Beyond $26.77 / +10.775 (+67.36%) 11:32 Today Bed Bath & Beyond trading resumes 11:27 Today Bed Bath & Beyond trading halted, volatility trading pause 08/15/22 Bed Bath & Beyond up another 16.5% amid increase in StockTwits message volume 08/03/22 Bed Bath & Beyond down 3% to $5.62 after Bloomberg report on credit talks BBBY Bed Bath & Beyond $26.77 / +10.775 (+67.36%) 12:56 Today Odeon Capital Bed Bath & Beyond downgraded to Sell from Hold at Odeon Capital 09:00 Today B. Riley B. Riley downgrades 'meme stock' Bed Bath & Beyond to Sell 05:48 Today B. Riley Bed Bath & Beyond downgraded to Sell from Neutral at B. Riley 08/09/22 Baird Baird downgrades Bed Bath & Beyond to sell after 86% two-day rally BBBY Bed Bath & Beyond $26.77 / +10.775 (+67.36%) 06/29/22 Bed Bath & Beyond reports Q1 adjusted EPS ($2.83), consensus ($1.39) 06/28/22 Notable companies reporting before tomorrow's open 06/28/22 Notable companies reporting before tomorrow's open 04/13/22 Bed Bath & Beyond reports Q4 adjusted EPS (92c), consensus 3c BBBY Bed Bath & Beyond $26.77 / +10.775 (+67.36%) 08/13/22 Royal Caribbean among companies at risk of liquidity squeeze, Barron's says 08/03/22 Bed Bath & Beyond weighing private loans, Bloomberg reports 08/03/22 Bed Bath & Beyond in talks with private credit providers, Bloomberg says 07/02/22 Bed Bath & Beyond remodeling not working, Barron's says BBBY Bed Bath & Beyond $26.77 / +10.775 (+67.36%) 12:02 Today What You Missed On Wall Street This Morning 09:52 Today Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/12/22 Short Report: Bed Bath Beyond shorts nudge higher as stock soars 08/09/22 What You Missed On Wall Street On Tuesday BBBY Bed Bath & Beyond $26.77 / +10.775 (+67.36%) 10:25 Today Bed Bath & Beyond call volume above normal and directionally bullish 08:55 Today Notable open interest changes for August 16th 08/15/22 Unusually active option classes on open August 15th 08/15/22 Notable open interest changes for August 15th
Recommendations	Farmers Edge price target lowered to C$1 from C$3 at CIBC » 14:32 08/16/22 08/16 14:32 08/16/22 14:32 FMEGF Farmers Edge / + CIBC analyst Kevin Chiang… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research FMEGF Farmers Edge / + 06/27/22 Farmers Edge announces departure of President Wortzman 04/05/22 Gevo, Farmers Edge partner to verify sustainable fuels FMEGF Farmers Edge / + 07/21/22 National Bank Farmers Edge price target lowered to C$2 from C$3 at National Bank 05/20/22 Raymond James Farmers Edge price target lowered to C$3.50 from C$4.50 at Raymond James 05/17/22 Canaccord Farmers Edge price target lowered to C$2.50 from C$3.50 at Canaccord 03/31/22 Canaccord Farmers Edge price target lowered to C$3.50 from C$4.50 at Canaccord
Recommendations	Canadian Western Bank price target lowered to C$30 from C$32 at CIBC » 14:32 08/16/22 08/16 14:32 08/16/22 14:32 CBWBF Canadian Western Bank $21.94 / + (+0.00%) CIBC analyst Paul Holden… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research CBWBF Canadian Western Bank $21.94 / + (+0.00%) 05/31/22 CIBC Canadian Western Bank price target lowered to C$32 from C$34 at CIBC 05/31/22 Credit Suisse Canadian Western Bank price target lowered to C$33 from C$35 at Credit Suisse 05/31/22 Desjardins Canadian Western Bank price target lowered to C$38 from C$44 at Desjardins 05/16/22 National Bank Canadian Western upgraded to Outperform from Sector Perform at National Bank
Recommendations	Bank of Nova Scotia price target lowered to C$87 from C$88 at CIBC » 14:32 08/16/22 08/16 14:32 08/16/22 14:32 BNS Bank of Nova Scotia $63.74 / +0.9 (+1.43%) CIBC analyst Paul Holden… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events BNS Bank of Nova Scotia $63.74 / +0.9 (+1.43%) 07/13/22 Bank of Nova Scotia raises Canadian prime lending rate to 4.7% from 3.7% 07/13/22 Scotiabank raises prime lending rate to 4.7% from 3.7% 04/13/22 Scotiabank raises Canadian dollar prime lending rate to 3.2% from 2.7% 03/02/22 Scotiabank raises prime lending rate to 2.7% from 2.45% BNS Bank of Nova Scotia $63.74 / +0.9 (+1.43%) 10:57 Today National Bank Bank of Nova Scotia price target lowered to C$90 from C$91 at National Bank 08/07/22 Keefe Bruyette Royal Bank of Canada downgraded to Underperform at Keefe Bruyette 05/27/22 Desjardins Bank of Nova Scotia price target lowered to C$94 from C$96 at Desjardins 05/26/22 Canaccord Bank of Nova Scotia price target raised to C$92 from C$89 at Canaccord BNS Bank of Nova Scotia $63.74 / +0.9 (+1.43%) 05/25/22 Bank of Nova Scotia reports Q2 EPS C$2.18 vs. C$1.90 last year 03/01/22 Bank of Nova Scotia reports Q1 adjusted EPS C$2.15 vs. C$1.88 a year ago BNS Bank of Nova Scotia $63.74 / +0.9 (+1.43%) 04/07/22 Trudeau windfall tax to hit Canadian banks and insurers, Bloomberg reports 08/23/22 Bank of Nova Scotia - BNS

Recommendations	Dialysis legislation could benefit DaVita, says Barclays » 14:31 08/16/22 08/16 14:31 08/16/22 14:31 DVA DaVita $93.23 / +0.89 (+0.96%) Barclays analyst Sarah… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Options DVA DaVita $93.23 / +0.89 (+0.96%) 06/27/22 DaVita COO buys $1.55M in common stock 06/22/22 Rockwell Medical receives second $7.5M investment from DaVita 06/22/22 DaVita schedules conference call to discuss Supreme Court ruling 06/21/22 DaVita down 10% following ruling from Supreme Court DVA DaVita $93.23 / +0.89 (+0.96%) 08/04/22 Barclays DaVita price target lowered to $103 from $128 at Barclays 08/02/22 Deutsche Bank DaVita price target lowered to $97 from $150 at Deutsche Bank 06/23/22 Barclays Barclays 'less optimistic' on quick DaVita CMS/legislative fix 06/22/22 Truist Fresenius Medical price target lowered to $27 from $34 at Truist DVA DaVita $93.23 / +0.89 (+0.96%) 08/01/22 DaVita backs FY22 adjusted EPS view $7.50-$8.50, consensus $7.87 08/01/22 DaVita reports Q2 EPS $2.30, consensus $2.09 05/05/22 DaVita sees FY22 adjusted EPS $7.50-$8.50, consensus $8.25 05/05/22 DaVita reports Q1 adjusted EPS $1.61, consensus $1.87 DVA DaVita $93.23 / +0.89 (+0.96%) 08/01/22 Fly Intel: After-Hours Movers 06/21/22 What You Missed On Wall Street On Tuesday 05/05/22 Fly Intel: After-Hours Movers DVA DaVita $93.23 / +0.89 (+0.96%) 07/08/22 Early notable gainers among liquid option names on July 8th 06/22/22 Early notable gainers among liquid option names on June 22nd
Recommendations	Bank of Montreal price target raised to C$143 from C$142 at CIBC » 14:31 08/16/22 08/16 14:31 08/16/22 14:31 BMO Bank of Montreal $105.39 / +2.12 (+2.05%) CIBC analyst Paul Holden… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events BMO Bank of Montreal $105.39 / +2.12 (+2.05%) 08/04/22 BMO Financial Group expands in Japan with securities license 07/20/22 BMO Financial Group to acquire Radicle Group, terms not disclosed 07/13/22 BMO Bank of Montreal raises prime lending rate to 4.7% from 3.7% 07/11/22 BMO Harris Bank increases minimum base pay to $20 per hour BMO Bank of Montreal $105.39 / +2.12 (+2.05%) 10:56 Today National Bank Bank of Montreal price target lowered to C$151 from C$152 at National Bank 08/07/22 Keefe Bruyette Royal Bank of Canada downgraded to Underperform at Keefe Bruyette 05/27/22 Desjardins Bank of Montreal price target lowered to C$155 from C$159 at Desjardins 05/26/22 Canaccord Bank of Montreal price target raised to C$157 from C$155 at Canaccord BMO Bank of Montreal $105.39 / +2.12 (+2.05%) 05/25/22 Bank of Montreal reports Q2 EPS C$3.23 vs. C$3.13 last year 03/01/22 Bank of Montreal reports Q1 adjusted EPS C$3.89 vs. C$3.06 last year BMO Bank of Montreal $105.39 / +2.12 (+2.05%) 07/26/22 BMO Harris suffers 'setback' in Ponzi scheme suit, American Banker says 07/08/22 Rogers experiencing broad network failure in Canada, Bloomberg reports 04/07/22 Trudeau windfall tax to hit Canadian banks and insurers, Bloomberg reports 08/30/22 Bank of Montreal - BMO
Options	B. Riley Principal 150 Merger Corp call volume above normal and directionally bullish » 14:25 08/16/22 08/16 14:25 08/16/22 14:25 FAZE FaZe Holdings $13.21 / +1.49 (+12.71%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News On The Fly Options FAZE FaZe Holdings $13.21 / +1.49 (+12.71%) 07/26/22 FaZe Clan launches 'FaZe Subs' exclusively on DoorDash 07/25/22 B. Riley Principal 150 Merger Corp trading resumes 07/25/22 B. Riley Principal 150 Merger Corp trading halted, volatility trading pause 07/20/22 FaZe Clan completes combination with B. Riley Principal 150 Merger FAZE FaZe Holdings $13.21 / +1.49 (+12.71%) 08/15/22 Fly Intel: After-Hours Movers FAZE FaZe Holdings $13.21 / +1.49 (+12.71%) 08/09/22 B. Riley Principal 150 Merger Corp call volume above normal and directionally bullish 07/20/22 One new option listing and two option delistings on July 20th
Technical Analysis	NASDAQ market internals summary » 14:17 08/16/22 08/16 14:17 08/16/22 14:17 $NSD NASDAQ Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 13:17 Today NASDAQ market internals summary 12:17 Today NASDAQ market internals summary 11:17 Today NASDAQ market internals summary 10:17 Today NASDAQ market internals summary
Periodicals	Frontier CEO tells Reuters company targets up to 20% capacity growth » 14:16 08/16/22 08/16 14:16 08/16/22 14:16 ULCC Frontier Group $14.29 / -0.335 (-2.29%) Frontier Group CEO Barty… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly ULCC Frontier Group $14.29 / -0.335 (-2.29%) 07/27/22 Spirit Airlines announces termination of merger agreement with Frontier 07/15/22 ISS formally recommends Spirit shareholders vote against Frontier transaction 07/15/22 ISS formally recommends Spirit shareholders vote against Frontier transaction 07/13/22 JetBlue CEO says 'standing ready' to enter binding merger agreement with Spirit ULCC Frontier Group $14.29 / -0.335 (-2.29%) 08/11/22 Barclays Frontier Group reinstated with an Overweight at Barclays 08/10/22 Barclays Frontier Group reinstated with an Overweight at Barclays 08/02/22 BofA Frontier Group resumed with a Buy at BofA 07/12/22 Susquehanna Frontier Group price target lowered to $13 from $15 at Susquehanna ULCC Frontier Group $14.29 / -0.335 (-2.29%) 07/27/22 Frontier Group sees Q3 adjusted pre-tax margin between 1%-5% 07/27/22 Frontier Group reports Q2 EPS 6c, consensus 7c 04/28/22 Frontier Group sees Q2 pre-tax margin between 1%-5% 04/28/22 Frontier Group reports Q1 EPS (56c), consensus (43c) ULCC Frontier Group $14.29 / -0.335 (-2.29%) 07/27/22 Spirit and Frontier Group agree to terminate merger agreement, Bloomberg says 07/27/22 Spirit Airlines vote on Frontier deal to go ahead, set to fail, Reuters reports 07/15/22 ISS now recommends Spirit holders vote against Frontier deal, CNBC reports 07/11/22 Frontier Group declines to raise bid for Spirit Airlines, Reuters reports ULCC Frontier Group $14.29 / -0.335 (-2.29%) 08/11/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/10/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/05/22 Sell these stocks now, proven algorithm says 07/28/22 What You Missed On Wall Street This Morning
Technical Analysis	NYSE market internals summary » 14:16 08/16/22 08/16 14:16 08/16/22 14:16 $NYE NYSE Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 13:16 Today NYSE market internals summary 12:16 Today NYSE market internals summary 11:16 Today NYSE market internals summary 10:16 Today NYSE market internals summary
General news	U.S. July retail sales (Wednesday) are the focus » 14:15 08/16/22 08/16 14:15 08/16/22 14:15 $ECON Economic Data / + U.S. July retail sales… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
Conference/Events	Novan management to meet virtually with Oppenheimer » 14:08 08/16/22 08/16 14:08 08/16/22 14:08 NOVN Novan $2.98 / -0.02 (-0.67%) Virtual Meetings to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events NOVN Novan $2.98 / -0.02 (-0.67%) 07/19/22 Novan satisfies $16.5M outstanding promissory note 07/13/22 Novan announces publication of 'positive' Phase 3 results in JAMA Dermatology 05/19/22 Novan to present berdazimer gel 10.3% clinical data 03/11/22 EP Group announces EPI Health acquisition by Novan NOVN Novan $2.98 / -0.02 (-0.67%) 07/19/22 Oppenheimer Novan initiated with an Outperform at Oppenheimer 10/19/21 Brookline Brookline starts Novan at Buy with $16 price target 10/19/21 Brookline Novan initiated with a Buy at Brookline NOVN Novan $2.98 / -0.02 (-0.67%) 08/11/22 Novan reports Q2 EPS (44c), consensus (57c) 05/16/22 Novan reports Q1 EPS (71c), consensus (60c) 02/22/22 Novan reports FY21 EPS ($1.74), two est. ($1.96) 08/17/22 Novan 08/18/22 Novan
Options	SoFi Technologies call volume above normal and directionally bullish » 14:05 08/16/22 08/16 14:05 08/16/22 14:05 SOFI SoFi Technologies $7.74 / +0.135 (+1.78%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options SOFI SoFi Technologies $7.74 / +0.135 (+1.78%) 08/09/22 SoftBank to sell 'some or all of their holdings' in SoFi Technologies 05/10/22 SoFi Technologies off lows after resumption, remains down 13% 05/10/22 SoFi Technologies trading resumes 05/10/22 SoFi Technologies to resume trading at 2:10 pm ET SOFI SoFi Technologies $7.74 / +0.135 (+1.78%) 08/03/22 Mizuho SoFi Technologies price target raised to $8 from $7 at Mizuho 07/08/22 Keefe Bruyette SoFi, LendingClub could be weak on Upstart miss, says Keefe Bruyette 07/07/22 Mizuho SoFi Technologies price target lowered to $7 from $9 at Mizuho 06/29/22 Piper Sandler SoFi Technologies price target lowered to $8 from $10 at Piper Sandler SOFI SoFi Technologies $7.74 / +0.135 (+1.78%) 08/02/22 SoFi raises FY22 adjusted revenue $1.508B-$1.513B from $1.505B-$1.51B 08/02/22 SoFi Technologies reports Q2 EPS (12c), consensus (13c) 08/02/22 Notable companies reporting after market close 05/10/22 SoFi Technologies sees FY22 adjusted revenue $1.505B-$1.51B, consensus $1.46B 16 Nov SOFI SoFi Technologies $7.74 / +0.135 (+1.78%) 07/26/22 Biden considering extending pause on student loans, Bloomberg reports 05/27/22 White House looks to forgive $10,000 in student debt per borrower, WaPo says 04/29/22 White House weighs student-loan forgiveness starting at $10,000, Bloomberg says 04/26/22 Biden says looking at forgiving most federal student loan debt, CBS News reports SOFI SoFi Technologies $7.74 / +0.135 (+1.78%) 06/13/22 Fly Insider: Tela Bio, Airbnb among week's notable insider trades 05/27/22 What You Missed On Wall Street On Friday 05/27/22 What You Missed On Wall Street This Morning 05/20/22 Proven algorithm says sell these stocks now SOFI SoFi Technologies $7.74 / +0.135 (+1.78%) 08/04/22 Notable open interest changes for August 4th 08/02/22 SoFi Technologies call volume above normal and directionally bullish 06/14/22 Notable open interest changes for June 14th 06/13/22 SoFi Technologies put volume heavy and directionally bearish
Hot Stocks	GSK says plaintiff in first U.S. Zantac trial to file for voluntary dismissal » 14:02 08/16/22 08/16 14:02 08/16/22 14:02 GSK GSK plc $35.24 / +0.31 (+0.89%) GSK plc issued the… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options GSK GSK plc $35.24 / +0.31 (+0.89%) 14:02 Today Correction: GSK says notice of voluntary dismissal to be filed in a Zantac case 08/15/22 Ideaya Biosciences down 34% after GSK waived option on IDE397 08/11/22 Haleon says it is not a party to any Zantac claims 08/11/22 GSK says no new 'material developments' related to Zantac litigation GSK GSK plc $35.24 / +0.31 (+0.89%) 06:11 Today Oppenheimer Ideaya Biosciences price target lowered to $20 from $25 at Oppenheimer 08/15/22 RBC Capital Haleon initiated with a Sector Perform at RBC Capital 08/15/22 Stifel Ideaya Biosciences downgraded to Hold at Stifel after GSK waives IDE397 opt-in 08/12/22 JPMorgan Sanofi may not be liable for any Zantac litigation damages, says JPMorgan GSK GSK plc $35.24 / +0.31 (+0.89%) 07/27/22 GSK plc reports Q2 adjusted EPS 34.7p vs. 28.2p last year 04/27/22 GlaxoSmithKline reaffirms FY22 sales growth between 5%-7% at CER 04/27/22 GlaxoSmithKline reports Q1 adjusted EPS 32.8p vs. 22.9p last year 04/13/22 GlaxoSmithKline backs FY22 revenue view up 5%-7% at CER, consensus $47.34B GSK GSK plc $35.24 / +0.31 (+0.89%) 13:37 Today GSK says notice of voluntary dismissal to be filed in Bayer case, Bloomberg says 09:25 Today AstraZeneca sues former dealmaker for sharing data with GSK, Bloomberg reports 08/11/22 GSK, Sanofi weakness related to Zantac litigation worries, Bloomberg reports 07/18/22 GSK CEO says split will help deal with 'perennial underperformance,' FT reports GSK GSK plc $35.24 / +0.31 (+0.89%) 12:02 Today What You Missed On Wall Street This Morning 08/11/22 What You Missed On Wall Street On Thursday 08/11/22 Renewed Zantac litigation concerns sinking these big-cap drugmakers 08/11/22 What You Missed On Wall Street This Morning 09/10/22 ESMO Congress 2022 GSK GSK plc $35.24 / +0.31 (+0.89%) 08/15/22 GSK plc (ADR) call volume above normal and directionally bullish 08/15/22 Unusually active option classes on open August 15th 08/12/22 Unusually active option classes on open August 12th 08/11/22 GSK plc (ADR) call volume above normal and directionally bullish

Recommendations	Rio Tinto price target lowered to 5,900 GBp from 5,990 GBp at Morgan Stanley » 13:53 08/16/22 08/16 13:53 08/16/22 13:53 RIO Rio Tinto $60.59 / +2.06 (+3.52%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Periodicals On The Fly Options RIO Rio Tinto $60.59 / +2.06 (+3.52%) 08/15/22 Rio Tinto reiterates proposal for acquisition of Turquoise Hill 08/03/22 Rio Tinto, Midland complete VTEM survey at Tete Nord Ni-Cu project 08/02/22 Royal Gold acquires royalty interest on Cortez mine in Nevada for $525M 07/21/22 Ford collaborates with mining companies to source Nickel through 2026 RIO Rio Tinto $60.59 / +2.06 (+3.52%) 07/29/22 Berenberg Rio Tinto price target raised to 4,300 GBp from 4,100 GBp at Berenberg 07/28/22 JPMorgan Rio Tinto price target raised to 5,350 GBp from 5,300 GBp at JPMorgan 07/28/22 UBS Rio Tinto price target lowered to 4,300 GBp from 4,400 GBp at UBS 07/28/22 RBC Capital Rio Tinto price target lowered to 4,700 GBp from 4,900 GBp at RBC Capital RIO Rio Tinto $60.59 / +2.06 (+3.52%) 04/18/22 Energy Department set to announce $6B nuclear plant lifeline, Bloomberg says 03/24/22 Apple to buy industrial-size batch of carbon-free aluminum, Reuters reports 03/09/22 Rio Tinto will end commercial relationships with Russian firms, Bloomberg says RIO Rio Tinto $60.59 / +2.06 (+3.52%) 08/15/22 What You Missed On Wall Street On Monday 08/15/22 What You Missed On Wall Street This Morning 03/29/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/25/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations RIO Rio Tinto $60.59 / +2.06 (+3.52%) 07/19/22 Rio Tinto put volume heavy and directionally bearish 07/14/22 Rio Tinto call volume above normal and directionally bullish 07/05/22 Rio Tinto call volume above normal and directionally bullish 06/10/22 Rio Tinto put volume heavy and directionally bearish
Recommendations	Fevertree price target lowered to 1,200 GBp from 1,600 GBp at Morgan Stanley » 13:52 08/16/22 08/16 13:52 08/16/22 13:52 FQVTF Fevertree Drinks $12.19 / -0.34 (-2.71%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research FQVTF Fevertree Drinks $12.19 / -0.34 (-2.71%) 07/26/22 JPMorgan Fevertree Drinks price target lowered to 1,100 GBp from 1,600 GBp at JPMorgan 07/22/22 Citi Fevertree Drinks price target lowered to 1,100 GBp at Citi 07/22/22 RBC Capital Fevertree Drinks downgraded to Underperform from Sector Perform at RBC Capital 07/21/22 UBS Fevertree Drinks price target lowered to 1,360 GBp from 2,660 GBp at UBS
Recommendations	Adecco price target lowered to CHF 33.10 from CHF 34.30 at Morgan Stanley » 13:52 08/16/22 08/16 13:52 08/16/22 13:52 AHEXY Adecco $17.63 / -0.389 (-2.16%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research AHEXY Adecco $17.63 / -0.389 (-2.16%) 08/11/22 RBC Capital Adecco price target lowered to CHF 48 from CHF 52 at RBC Capital 08/05/22 JPMorgan Adecco price target lowered to CHF 30 from CHF 32 at JPMorgan 07/13/22 JPMorgan Adecco price target lowered to CHF 32 from CHF 35 at JPMorgan 06/27/22 Morgan Stanley Adecco price target lowered to CHF 34.30 from CHF 51.50 at Morgan Stanley
Recommendations	HelloFresh price target raised to EUR 37 from EUR 35 at Morgan Stanley » 13:51 08/16/22 08/16 13:51 08/16/22 13:51 HLFFF HelloFresh $31.54 / +1.43 (+4.75%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research HLFFF HelloFresh $31.54 / +1.43 (+4.75%) 12:40 Today JPMorgan HelloFresh price target raised to EUR 35 from EUR 34 at JPMorgan 08/08/22 JPMorgan HelloFresh price target lowered to EUR 34 from EUR 37 at JPMorgan 07/25/22 Credit Suisse HelloFresh price target lowered to EUR 58 from EUR 84 at Credit Suisse 07/22/22 Morgan Stanley HelloFresh price target lowered to EUR 35 from EUR 46 at Morgan Stanley
Downgrade	Rattler Midstream downgraded to Equal Weight from Overweight at Wells Fargo » 13:50 08/16/22 08/16 13:50 08/16/22 13:50 RTLR Rattler Midstream $14.09 / -0.33 (-2.29%) Wells Fargo analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly RTLR Rattler Midstream $14.09 / -0.33 (-2.29%) 05/16/22 Diamondback Energy to acquire publicly held units of Rattler Midstream RTLR Rattler Midstream $14.09 / -0.33 (-2.29%) 05/17/22 Wells Fargo Diamondback Energy price target lowered to $200 from $204 at Wells Fargo 05/02/22 Truist Rattler Midstream assumed with a Hold at Truist 03/25/22 Citi Rattler Midstream price target raised to $15 from $10 at Citi RTLR Rattler Midstream $14.09 / -0.33 (-2.29%) 08/03/22 Rattler Midstream reports Q2 EPS 30c, consensus 32c 05/03/22 Rattler reports Q1 EPS 19c, consensus 32c RTLR Rattler Midstream $14.09 / -0.33 (-2.29%) 05/16/22 What You Missed On Wall Street On Monday

Events

Earnings calls, analyst events, roadshows and more

UCBI
Today at 16:00

United Community Banks - UCBI Conference Calls
UAVS
Today at 16:30

Ageagle Aerial Systems - UAVS Conference Calls
PIK
Today at 16:30

Kidpik - PIK Conference Calls
CUE
Today at 16:30

Cue Biopharma - CUE Conference Calls
QBTS
Today at 16:30

D-Wave Quantum - QBTS Conference Calls
A
Today at 16:30

Agilent - A Conference Calls
PAVM
Today at 16:30

PAVmed - PAVM Conference Calls
SDIG
Today at 16:30

Stronghold Digital Mining - SDIG Conference Calls
PAVM
Today at 16:30

PAVmed - PAVM Conference Calls
SPI
Today at 16:30

SPI Energy - SPI Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	BROS X BROS Dutch Bros Block Trade Managers: Morgan Stanley Priced at: $43.50 5.97M Shares LUCY X LUCY Innovative Eyewear IPO Managers: Maxim Priced at: $7.50 980K Shares SVFD X SVFD Save Foods Secondary Managers: ThinkEquity Priced at: $3.00 1.6M Shares FULC X FULC Fulcrum Therapeutics Spot Secondary Managers: Goldman Sachs & SVB Securities, Stifel, Oppenheimer Priced at: $7.82 9.591M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TELA X TELA Tela Bio Spot Secondary Managers: Lake Street Priced at: $8.00 4M Shares TRIN X TRIN Trinity Capital Spot Secondary Managers: Keefe Bruyette, Morgan Stanley, UBS & Wells Fargo Priced at: $15.33 3.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	DVAX X DVAX Dynavax Block Trade Managers: Goldman Sachs $14.85-15.62 3M Shares GRFX X GRFX Graphex Group Secondary Managers: EF Hutton $2.00-3.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	BE X BE Bloom Energy Secondary Managers: JPMorgan, Morgan Stanley & BofA $30.36 13M Shares VRDN X VRDN Viridian Therapeutics Secondary Managers: Jefferies, SVB Securities & Evercore ISI $22.00 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	No deals
Thurs	GFRX X GFRX Graphex Group Secondary Managers: EF Hutton $2.00-3.00 8M Shares
Fri	No deals

View All Syndicate Announcements »

Immunocore and Medison Pharma extend multi-territorial agreement for Kimmtrak

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access